Oct. 25 at 6:41 AM
$SLS $2.X per share is about
$250M in Market Value.
This will quadruple to
$1B and Still have 2,000% more Upside.
A Positive P3 Result is worth
$20B to
Big Pharma all day long.
$8.X to
$10 in Play Before the P3 Results are announced - followed by a Gap Up into the
$40/
$50 Range on the Announcement and Given the massive Value, will keep Climbing - Just Like
$ABVX Did.
Pro tip: When Gps announces a 3x 4x OS Advantage for AML CR2 Patients - Every AML CR1 Patient on the planet, all 35,000 each year will want Gps Treatment.
- any Buyer will absolutely include this expanded Market in their Consideration.
